Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Humacyte, Inc. | Chief Commercial Officer | Common Stock | 15.5K | $18.5K | $1.19 | Dec 13, 2022 | Direct |
Humacyte, Inc. | Chief Commercial Officer | Stock Options (right to buy) | 276K | Dec 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HUMA | Humacyte, Inc. | Dec 8, 2023 | 1 | $0 | 4 | Dec 12, 2023 | Chief Commercial Officer |
HUMA | Humacyte, Inc. | Dec 13, 2022 | 1 | $15.5K | 4 | Dec 15, 2022 | Chief Commercial Officer |
HUMA | Humacyte, Inc. | Dec 8, 2022 | 1 | $0 | 4 | Dec 12, 2022 | Chief Commercial Officer |
HUMA | Humacyte, Inc. | May 24, 2022 | 1 | $49.7K | 4 | May 25, 2022 | Chief Commercial Officer |
HUMA | Humacyte, Inc. | Oct 13, 2021 | 1 | $0 | 4 | Oct 15, 2021 | Chief Commercial Officer |
HUMA | Humacyte, Inc. | Aug 26, 2021 | 0 | $0 | 3 | Aug 27, 2021 | Chief Commercial Officer |